They are typically low-grade endometrioid carcinomas with a good prognosis. For example, patients with CN-low/p53-wildtype endometrial tumors often present with early-stage, well-differentiated endometrioid adenocarcinomas. This evidence concerns the gene TP53 and endometrioid adenocarcinoma.